Palatin Technologies, Inc. Common Stock (PTN) Stock Price

PTNStock
$10.37+7.97%52W
Market Cap$18.45M
P/E
PEG Ratio1.62
Div yield
Beta0.66

PTN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-58.74%
Price vs S&P 500 (4W)29.24%
PEG Ratio1.62
VGM Score71.30

PTN Earnings Surprise History

Q3 254.26est.
Q4 25-2.86est. -1.47
Q1 26-0.37est. -0.82

PTN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.00
4.00
4.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PTNPalatin Technologies, Inc. Common Stock
AAD$10.37
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Palatin Technologies, Inc. Common Stock

Palatin Technologies is a biopharmaceutical company developing first-in-class, receptor-specific medicines that modulate the melanocortin receptor system. The company targets diseases with unmet medical needs and significant commercial potential. Palatin operates as a focused life science business.